Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities

Bernie Sweeney, R&D Director Cell Expression Systems at Lonza Pharma & Biotech, provides an overview of the growing "zoo" of novel protein formats, including bi- and multispecific antibodies.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: